Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine augmentation of ECT in depression
2011-005476-41Phase 4Completed
- Sponsor
- Manchester Mental Health and Social Care NHS Trust
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in major depressive episode (MDE), major depressive disorder (MDD), sponsored by Manchester Mental Health and Social Care NHS Trust. Started May 2012; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive episode (MDE)major depressive disorder (MDD)
Beyond the preview
Go deeper on 2011-005476-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005476-41.